InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Renee PremiumMember
09/14/23 12:28 PM
profile icon
halbroke1 Free
02/18/21 7:51 PM
profile icon
halbroke1 Free
11/30/20 10:54 AM
profile icon
gmoney305 Free
08/11/20 12:22 AM
profile icon
mick Grandfathered
08/10/20 11:45 PM
profile icon
mick Grandfathered
07/17/20 12:32 PM
profile icon
halbroke1 Free
05/18/20 2:37 PM
profile icon
halbroke1 Free
04/28/20 5:43 PM
profile icon
makinezmoney Free
04/20/20 11:31 AM
profile icon
halbroke1 Free
04/19/20 4:04 PM
profile icon
makinezmoney Free
04/15/20 3:03 PM
profile icon
halbroke1 Free
04/14/20 2:27 PM
profile icon
makinezmoney Free
04/14/20 12:22 PM
profile icon
halbroke1 Free
04/14/20 12:16 PM
profile icon
halbroke1 Free
04/14/20 12:14 PM
profile icon
halbroke1 Free
01/08/20 12:28 AM
profile icon
halbroke1 Free
11/17/19 10:13 PM
profile icon
halbroke1 Free
07/16/19 5:48 PM
profile icon
halbroke1 Free
06/05/19 1:18 PM
profile icon
makinezmoney Free
06/05/19 12:40 PM
profile icon
HerGoblin Free
01/23/19 1:24 PM
profile icon
Longer Than Most Free
08/21/17 4:42 AM
profile icon
Longer Than Most Free
08/16/17 2:56 PM
profile icon
Longer Than Most Free
08/16/17 2:17 PM
profile icon
Longer Than Most Free
06/24/17 9:13 PM
profile icon
Longer Than Most Free
06/23/17 2:37 PM
profile icon
Longer Than Most Free
06/20/17 9:48 AM
profile icon
Longer Than Most Free
06/02/17 4:21 PM
profile icon
Longer Than Most Free
06/01/17 10:48 AM
profile icon
Longer Than Most Free
05/30/17 4:57 PM
profile icon
Longer Than Most Free
05/25/17 2:46 PM
profile icon
Longer Than Most Free
02/01/17 4:01 PM
profile icon
Longer Than Most Free
01/27/17 4:01 PM
profile icon
Longer Than Most Free
01/27/17 3:34 PM
profile icon
Longer Than Most Free
01/27/17 12:38 PM
profile icon
Longer Than Most Free
01/26/17 12:22 PM
profile icon
Longer Than Most Free
01/24/17 5:52 PM
profile icon
LostBall Free
01/24/17 11:52 AM
profile icon
Longer Than Most Free
01/24/17 11:44 AM
profile icon
LostBall Free
01/24/17 11:41 AM
profile icon
Longer Than Most Free
01/24/17 11:36 AM
profile icon
Longer Than Most Free
01/24/17 11:32 AM
profile icon
LostBall Free
01/24/17 10:06 AM
profile icon
Longer Than Most Free
01/24/17 9:59 AM

EPIRUS Biopharmaceuticals, Inc. (EPRSQ) RSS Feed

Followers
22
Posters
95
Posts (Today)
0
Posts (Total)
714
Created
04/15/15
Type
Free
Moderators
EPIRUS Biopharmaceuticals, Inc. 699 Boylston Street 8th Floor Boston, MA 02116 United States Phone: 617-600-4313 Website: http://www.epirusbiopharma.com EPIRUS Biopharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops, manufactures, and commercializes biosimilar therapeutics worldwide. Its lead product candidate is BOW015, a biosimilar version of Remicade (infliximab) for the treatment of various inflammatory diseases. The company’s pipeline of biosimilar product candidates also include BOW050, a biosimilar version of Humira (adalimumab) to treat inflammatory diseases, including rheumatoid arthritis and various other forms of adult and pediatric arthritis, ankylosing spondylitis, inflammatory bowel disease, and chronic psoriasis and psoriasis; and BOW070, a biosimilar version of Actemra (tocilizumab) for the treatment of rheumatoid arthritis, polyarticular arthritis, and systemic juvenile idiopathic arthritis. It has a license agreement with Ranbaxy Laboratories Limited; license and collaboration agreement with Livzon Mabpharm Inc.; and license agreement with Bioceros B.V. The company is headquartered in Boston, Massachusetts.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
EPRSQ Latest News
  • No Recent News Available for this company!
New Post